A Novel Therapeutic Approach for Managing Hidden Epidemic of FLA1c in Patients with T2DM Dr. Kamal Kant Kohli31 May 2023 10:15 AM ISTNon-alcoholic fatty liver disease (NAFLD) affects up to one-third of the general population worldwide. Type 2 diabetes mellitus (T2DM) and obesity...
USV launches Pioz-V for uncontrolled diabetic patients with fatty liver Dr. Nandita Mohan25 April 2023 2:09 PM ISTMumbai: USV Pvt. Ltd, a leading drug manufacturer in the anti-diabetic segment, has announced the launch of the brand Pioz-V for the treatment of...
SGLT2 inhibitors improve FIB-4 index better than pioglitazone in MAFLD patients Aditi20 March 2023 10:30 AM ISTJapan: A study entitled "Effects of sodium-glucose cotransporter two inhibitors and pioglitazone on FIB-4 index in metabolic associated fatty liver...
Add on pioglitazone effective for type 2 diabetes patients with alcoholic fatty liver disease Medha Baranwal1 March 2023 11:15 AM ISTJapan: Pioglitazone could also be an effective treatment option for type 2 diabetes (T2D) patients with alcoholic fatty liver disease (AFLD), a recent...
Pioglitazone may protect against dementia in diabetes patients Dr. Kamal Kant Kohli18 Feb 2023 9:30 AM ISTSouth Korea: The use of the diabetes drug pioglitazone may lower the risk of dementia in people with type 2 diabetes mellitus (T2DM), a recent study...
Alkem Gets CDSCO panel nod to manufacture, market antidiabetic FDC Drug Dr. Divya Colin1 Feb 2023 6:00 PM ISTNew Delhi: The drug major, Alkem Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Is Pioglitazone Safe? Chennai Diabetologist plans to approach SC seeking answers Barsha Misra12 Jan 2023 4:45 PM ISTChennai: Seeking clarity regarding the safety of pioglitazone, a Chennai-based medical specialist in diabetes is planning to approach the Supreme...
Glenmark Pharma unveils triple FDC Zita-PioMet for Type 2 diabetes in India Ruchika Sharma23 Dec 2022 11:15 AM ISTThis offers patients with Type 2 diabetes the convenience of once-daily dosing to improve their glycemic control and achieve the targeted HbA1c within...
Pioglitazone reverses hair loss in patient with cicatricial alopecia: Case report Medha Baranwal6 Nov 2022 8:45 PM ISTUSA: In a recent case study published in JAAD Case Reports, the researchers from the USA have described an exceptional case of hair regrowth with oral...
Anti-diabetic drug and NASH: Current Options in 2022 Dr. Kamal Kant Kohli9 Jun 2022 11:06 AM ISTIntroduction and Background Nonalcoholic steatohepatitis (NASH) is a more aggressive form of nonalcoholic fatty liver disease, which can increase the...
Triple Drug Therapy improves Hepatic Outcomes and Insulin sensitivity in diabetics MD Bureau10 Dec 2021 9:30 AM ISTHepatic steatosis is common among patients with type 2 diabetes (T2D). Approximately 70% of patients who are obese or who have type 2 diabetes develop...
Low- dose Pioglitazone improves NAFLD in type 2 diabetes: Study Dr. Shravani Dali29 July 2021 9:30 AM ISTComplete 1-year treatment with low- dosage pioglitazone shows significant improvement in non-alcoholic fatty liver disease independent of glycaemic...
